Targeting the Ubiquinol-Reduction (Qi) Site of the Mitochondrial Cytochrome bc1 Complex for the Development of Next Generation Quinolone Antimalarials (original) (raw)

Subtle changes in endochin-like quinolone (ELQ) structure alter site of inhibition within the cytochrome bc 1 complex of Plasmodium falciparum

David Fidock

Antimicrobial Agents and Chemotherapy, 2015

View PDFchevron_right

Insights into cytochrome bc1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling

David Rodrigues da Rocha

Memórias do Instituto Oswaldo Cruz, 2017

View PDFchevron_right

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria

raman sharma

Proceedings of the National Academy of Sciences of the United States of America, 2012

View PDFchevron_right

2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities

Thulie Paulinne Jimenez Villalobos

Journal of Molecular Graphics and Modelling, 2013

View PDFchevron_right

HDQ, a Potent Inhibitor of Plasmodium falciparum Proliferation, Binds to the Quinone Reduction Site of the Cytochrome bc1 Complex

Paul Oneill

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Exploring the Molecular Basis of Qo bc1 Complex Inhibitors Activity to Find Novel Antimalarials Hits

Daniel J V A dos Santos

Mol. Inf., 2013

View PDFchevron_right

Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1

Svetlana Antonyuk

Proceedings of the National Academy of Sciences of the United States of America, 2015

View PDFchevron_right

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

Paul Oneill

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Potent Antimalarial 2-Pyrazoyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-Like Properties

Svetlana Antonyuk

ACS Medicinal Chemistry Letters

View PDFchevron_right

In silico Anti-malaria Activity of Quinolone Compounds against Plasmodium falciparum Dihydrofolate Reductase (pfDHFR)

Oluwatosin Saibu

International Journal of Biochemistry Research & Review

View PDFchevron_right

A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor

Case McNamara, Badry Bursulaya

ACS Chemical Biology, 2011

View PDFchevron_right

Targeted Structure–Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc1 and Identifies ELQ-400 as a Remarkably Effective Compound against Acute Experimental Toxoplasmosis

Stone Doggett

ACS Infectious Diseases, 2018

View PDFchevron_right

Novel Conjugated Quinoline–Indoles Compromise Plasmodium falciparum Mitochondrial Function and Show Promising Antimalarial Activity

Jonathan Baell

Journal of Medicinal Chemistry, 2013

View PDFchevron_right

Molecular Dynamics, Inhibitive, Structural Activity, and Toxicity Studies of Novel 4-aminoquinoline Imidazole Analogues Against Chloroquine-Resistant-Plasmodium falciparum (3D7 strain)

Taofeek Saliu

Research Square (Research Square), 2023

View PDFchevron_right

Cytochrome b Mutations That Modify the Ubiquinol-binding Pocket of the Cytochrome bc1 Complex and Confer Anti-malarial Drug Resistance in Saccharomyces cerevisiae

Philip Hill

Journal of Biological Chemistry, 2005

View PDFchevron_right

Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis

Paola Gramatica

Journal of Molecular Graphics and Modelling, 2013

View PDFchevron_right

Diversity-Oriented Synthesis Probe Targets Plasmodium falciparum Cytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site Inhibitors

Kevin J Galinsky

The Journal of infectious diseases, 2015

View PDFchevron_right

A Quest for New Antimalarial Agents with Improved Specificity Guided by Molecular Docking, 3D QSAR and Molecular Dynamics Simulation Studies

Vijjulatha Manga

Asian Journal of Chemistry, 2018

View PDFchevron_right

Structure–activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum

Victor Melendez

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

Binding of Quinoline-Based Inhibitors to Plasmodium falciparum Lactate Dehydrogenase: A Molecular Docking Study

Jeremy Eberle

Open Journal of Biophysics, 2013

View PDFchevron_right

Antimalarial quinolones: Synthesis, potency, and mechanistic studies

Rozalia Dodean, David Hinrichs

Experimental Parasitology, 2008

View PDFchevron_right

Structure-based de novo design, molecular docking and molecular dynamics of primaquine analogues acting as quinone reductase II inhibitors

Andre Pimentel

View PDFchevron_right

Discovery, Synthesis, and Optimization of Antimalarial 4(1H)-Quinolone-3-Diarylethers

Sovitj Pou

Journal of Medicinal Chemistry, 2014

View PDFchevron_right

Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as Pf eEF2

Irene Hallyburton

ChemMedChem, 2022

View PDFchevron_right

QSAR, molecular docking and ADMET studies of quinoline, isoquinoline and quinazoline derivatives against Plasmodium falciparum malaria

EL RHABORI Said, Khalil Fouad

Structural Chemistry

View PDFchevron_right